Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Prevention Research

Abstract 2797: Dietary administration of a γ-tocopherol rich mixture of tocopherols inhibits estrogen-mediated mammary tumorigenesis

Soumyasri Das Gupta, Sudathip Sae-tan, Joseph Wahler, Jae Young So, Larry C. Cheng, Min Ji Bak, Mao-Jung Lee, Yong Lin, Weichung Joe Shih, Chung S Yang and Nanjoo Suh
Soumyasri Das Gupta
Rutgers University, Piscataway, NJ.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sudathip Sae-tan
Rutgers University, Piscataway, NJ.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Wahler
Rutgers University, Piscataway, NJ.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jae Young So
Rutgers University, Piscataway, NJ.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Larry C. Cheng
Rutgers University, Piscataway, NJ.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min Ji Bak
Rutgers University, Piscataway, NJ.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mao-Jung Lee
Rutgers University, Piscataway, NJ.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yong Lin
Rutgers University, Piscataway, NJ.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weichung Joe Shih
Rutgers University, Piscataway, NJ.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chung S Yang
Rutgers University, Piscataway, NJ.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nanjoo Suh
Rutgers University, Piscataway, NJ.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2015-2797 Published August 2015
  • Article
  • Info & Metrics
Loading
Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA

Abstract

Tocopherols (T), members of the vitamin E family, occur in four forms designated as α, β, δ and γ. Tocopherols are suggested to reduce the risk of cancer. α-T is the predominant form of tocopherols found in human tissues. However, clinical studies with α-T have provided inconclusive results. γ-T is our major dietary source of tocopherols. Recent studies have demonstrated that γ-T has higher anti-cancer activity than α-T in animal models of cancer. This study investigated the cancer preventive activity of a naturally occurring γ-T rich mixture of tocopherols (γ-TmT) in two different in vivo models of estrogen receptor (ER)-positive breast cancer, namely estrogen supplemented August-Copenhagen Irish (ACI) rats and MCF-7 xenograft tumor mouse models. ACI rats were subcutaneously implanted with 9 mg of 17β-estradiol (E2) in silastic tubings and administered with diets containing 0.05%, 0.1%, 0.3% and 0.5% γ-TmT. Rats were euthanized at early (6 weeks), intermediate (18 weeks) and late (31 weeks) stages of E2-induced mammary carcinogenesis. Treatment with 0.3% and 0.5% γ-TmT reduced the tumor volume by 51% (p<0.01) and 41% (p<0.01), respectively while the lower doses of γ-TmT (0.05% and 0.1%) were not effective. Tumor multiplicity was also reduced by 38% (p<0.02) and 32% (p<0.02) in the 0.3% and 0.5% γ-TmT treatment groups, respectively. Dietary γ-TmT increased the levels of tocopherols and their metabolites in the serum. Serum levels of E2 were significantly lowered in the 0.3% and 0.5% γ-TmT administered groups. Analysis of mammary glands and tumors revealed that γ-TmT led to induced mRNA expression of the estrogen metabolizing enzyme, CYP1A1 at each experimental time point. CYP1A1 metabolizes E2 to its non-carcinogenic metabolite, 2-hydroxyestradiol. Gene expression of the Nrf2 mediated phase II detoxification enzymes NQO1, GCLM, UGT1A1, COMT and the antioxidant enzyme heme oxygenase were also upregulated in the γ-TmT treated groups. Thus, γ-TmT exerts its protective activity in E2-induced mammary carcinogenesis by lowering the levels of available E2 through increased metabolism of E2 and simultaneous removal of E2 metabolites through induction of the antioxidant response pathway. mRNA levels of PPARγ, a nuclear receptor which inhibits cell proliferation was also induced in the 0.3% and 0.5% γ-TmT treated groups. In a second in vivo model, the ER positive breast cancer cell line, MCF-7 was utilized. Mice were injected with MCF-7 cells after implantation of E2 pellets. Effect of the different doses of dietary γ-TmT (0.05%, 0.1%, 0.3% and 0.5%) treatment on the mammary xenograft tumors was studied. A significant reduction in the volume and weight of mammary tumors was observed in each of the γ-TmT treatment groups. In conclusion, γ-TmT inhibits mammary tumorigenesis in two different in vivo models of E2-induced breast cancer and could be a potential safe, natural agent for the chemoprevention of ER-positive breast cancer.

Citation Format: Soumyasri Das Gupta, Sudathip Sae-tan, Joseph Wahler, Jae Young So, Larry C. Cheng, Min Ji Bak, Mao-Jung Lee, Yong Lin, Weichung Joe Shih, Chung S Yang, Nanjoo Suh. Dietary administration of a γ-tocopherol rich mixture of tocopherols inhibits estrogen-mediated mammary tumorigenesis. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 2797. doi:10.1158/1538-7445.AM2015-2797

  • ©2015 American Association for Cancer Research.
Previous
Back to top
Cancer Research: 75 (15 Supplement)
August 2015
Volume 75, Issue 15 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 2797: Dietary administration of a γ-tocopherol rich mixture of tocopherols inhibits estrogen-mediated mammary tumorigenesis
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract 2797: Dietary administration of a γ-tocopherol rich mixture of tocopherols inhibits estrogen-mediated mammary tumorigenesis
Soumyasri Das Gupta, Sudathip Sae-tan, Joseph Wahler, Jae Young So, Larry C. Cheng, Min Ji Bak, Mao-Jung Lee, Yong Lin, Weichung Joe Shih, Chung S Yang and Nanjoo Suh
Cancer Res August 1 2015 (75) (15 Supplement) 2797; DOI: 10.1158/1538-7445.AM2015-2797

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 2797: Dietary administration of a γ-tocopherol rich mixture of tocopherols inhibits estrogen-mediated mammary tumorigenesis
Soumyasri Das Gupta, Sudathip Sae-tan, Joseph Wahler, Jae Young So, Larry C. Cheng, Min Ji Bak, Mao-Jung Lee, Yong Lin, Weichung Joe Shih, Chung S Yang and Nanjoo Suh
Cancer Res August 1 2015 (75) (15 Supplement) 2797; DOI: 10.1158/1538-7445.AM2015-2797
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Prevention Research

  • Abstract LB-174: Patient navigation in Appalachia: results from a survey of current practices
  • Abstract LB-170: A novel, nontoxic RXR agonist, UAB30, targets Fanconi anemia DNA repair pathway to act as potent cancer chemopreventive agent
  • Abstract LB-153: Lotus leaf and Cassia seed extracts, through activating Nrf2 pathway, suppress TPA-induced mouse skin cell transformation
Show more 3

Poster Presentations - Proffered Abstracts

  • Abstract LB-236: Risk of tMDS/AML after chemotherapy for first primary lymphoid malignancy, 2000-2013
  • Abstract LB-001: Impact of direct physician engagement with racial/ethnic minorities for oncology clinical trial access and accrual model
  • Abstract LB-107: EV-TRACK: transparent reporting and centralizing knowledge of extracellular vesicles to support the validation of extracellular vesicle biomarkers in cancer research
Show more 3

Poster Presentations - Chemoprevention 1

  • Abstract 2823: Honokiol inhibits the invasive potential of melanoma cells by targeting NADPH oxidase 1 and decreasing the binding of core proteins
  • Abstract 2825: Prevention of breast tumor growth by an extract from the muscadine grape
  • Abstract 2826: Equimolar vs. pharmacokinetics-guided dosing in anti-cancer efficacy assessment of precursor-product pairs: Example with pyranocoumarins from Korean Angelica
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement